https://www.marketscreener.com/quote/stock/CORVUS-PHARMACEUTICALS-IN-26786329/news/Corvus-Pharmaceuticals-Inc-Presents-New-Interim-Soquelitinib-Data-from-its-Phase-1-1b-T-Cell-Lymph-45540326/?utm_source=telegram&utm_medium=social&utm_campaign=share